[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"metabolic-encephalopathy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:metabolic-encephalopathy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100326828","prognostic-significance-of-fatty-liver-disease-in-bariatric-patients-100326828",false,"NCT03535142","Prognostic Significance of Fatty Liver Disease in Bariatric Patients","PROMETHEUS","Inclusion Criteria case group:\n\n* Age \\> 18 years\n* BMI \\>35 kg\u002Fm2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark\n* Able to give written informed consent.\n\nInclusion criteria control group:\n\n* Age \\> 18 years\n* BMI \\>35 kg\u002Fm2 with no wish to undergo bariatric surgery.\n* Able to give written informed consent.\n\nExclusion Criteria:\n\n* Active viral hepatitis\n* Not willing or able to consent\n* Contraindications to liver biopsy","ALL","18 Years",{"count":19,"type":20},1200,"ESTIMATED","INTERVENTIONAL",[23],"NA","Prospective non-randomized intervention case control study on patients with a BMI \\> 35. The intervention group\u002Fcases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.",[26,27,28,29],"Non-Alcoholic Fatty Liver Disease","Metabolic Encephalopathy","Obesity, Morbid","Non-alcoholic Steatohepatitis","RECRUITING","2025-03-03",{"date":33,"type":34},"2025-03-05","ACTUAL",{"date":36,"type":34},"2018-08-15",{"date":38,"type":20},"2038-04-01",{"name":40,"class":41},"Esbjerg Hospital - University Hospital of Southern Denmark","OTHER"]